Position in ANAB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$26,437,522
+$6,243,392 QoQ
Shares Held
391,667
-28.3% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#23
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. ANAB ranks #28 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,437,522 | 391,667 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $20,194,130 | 364,121 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $14,515,687 | 299,416 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $5,919,662 | 193,327 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $183,682 | 8,274 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $153,813 | 8,274 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $598,238 | 45,184 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $10,627,623 | 317,243 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $903,590 | 36,057 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $811,641 | 36,041 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $771,698 | 36,027 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $647,043 | 36,027 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $733,134 | 36,044 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $29,153,200 | 1,339,758 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $73,539,981 | 2,373,023 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $60,533,384 | 2,372,923 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $46,773,053 | 2,304,097 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $39,662,765 | 1,603,187 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $55,749,053 | 1,604,287 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $25,554,443 | 942,273 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $23,425,388 | 903,407 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $24,400,432 | 1,132,268 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $28,364,540 | 1,319,284 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $20,738,916 | 1,406,033 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $31,617,954 | 1,415,310 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $17,998,327 | 1,273,767 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||